A four-legged precedent for generic user fees

Discussions between FDA and the Generic Pharmaceutical Association about the creation of a user fee program are on hold, but some generic drug companies are moving forward with another such program - this one for animal products. Led by Ivax's animal health division, the Generic Animal Drug Association has worked out a plan with the administration to add a generic component to the renewal of the animal drug user fee program now working its way through Congress. Whether the program will serve as a guide dog or a canary in the coal mine for the human generic industry remains to be seen